Publicaciones en colaboración con investigadores/as de University of Oxford (22)

2024

  1. Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-priming

    Immunological Reviews, Vol. 321, Núm. 1, pp. 143-151

  2. Ivermectin resistance mechanisms in ectoparasites: a scoping review

    Parasitology Research, Vol. 123, Núm. 5

2023

  1. A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors

    Malaria Journal, Vol. 22, Núm. 1

  2. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

    Science advances, Vol. 9, Núm. 33, pp. eadf6692

  3. Druggable Targets in Cytokine Release Syndromes

    Clinical Cancer Research, Vol. 29, Núm. 21, pp. 4320-4322

  4. Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s.

    Parasites and Vectors, Vol. 16, Núm. 1

  5. Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 23, pp. 4711-4727

  6. Interleukin-18 in cancer immunology and immunotherapy

    Expert Opinion on Therapeutic Targets, Vol. 27, Núm. 11, pp. 1035-1042

  7. Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 668-682

  8. Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic

    OncoImmunology, Vol. 12, Núm. 1

  9. Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma

    Cell Reports Medicine, Vol. 4, Núm. 4

2022

  1. Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

    Clinical Infectious Diseases, Vol. 75, Núm. 1, pp. E585-E593

  2. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19

    Chest, Vol. 162, Núm. 5, pp. 1006-1016

2021

  1. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?

    PLoS Neglected Tropical Diseases, Vol. 15, Núm. 3

  2. Malaria in Venezuela: Gabaldón's legacy scattered to the winds

    The Lancet Global Health

  3. Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

    Parasites and Vectors, Vol. 14, Núm. 1

  4. The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes

    PLoS Pathogens, Vol. 17, Núm. 3

  5. Treatment of pregnant women with ivermectin during mass drug distribution: Time to investigate its safety and potential benefits

    Pathogens, Vol. 10, Núm. 12

2020

  1. Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis

    The Lancet Global Health, Vol. 8, Núm. 1, pp. e92-e100

2019

  1. #EUROmicroMOOC: using Twitter to share trends in Microbiology worldwide

    FEMS microbiology letters, Vol. 366, Núm. 11